世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033315

ペプチド治療薬の世界市場レポート(2022年)

The Business Research Company

Peptide Therapeutics Global Market Report 2022

発刊日 2022/09/30

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000033315

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界のペプチド治療薬市場を評価するために必要な重要な情報を提供します。

本レポートは、力強い成長を経験しているペプチド治療薬市場に焦点を当てています。本 レポートは、世界的大パンデミックの課題への市場の対応を含め、今後10年以上にわたって私たちの生活を形作り変化させるペプチド治療薬市場へのガイドを提供します。

調査範囲

  • 調査市場
    ➣ タイプ別
      ◇ ジェネリック
      ◇ ブランド
    ➣ 投与経路別
      ◇ 非経口
      ◇ 粘膜
      ◇ 経口
      ◇ 経皮
    ➣ 用途別
      ◇ 癌
      ◇ 心血管疾患
      ◇ 中枢神経系
      ◇ 代謝障害
      ◇ 感染症
      ◇ 血液障害
      ◇ 胃腸障害
      ◇ 皮膚科
      ◇ 呼吸器障害
      ◇ 先端巨大症
      ◇ その他の用途
  • 調査企業
    ➣ Amgen, Inc.
    ➣ Pfizer, Inc.
    ➣ Bristol-Myers Squibb Company
    ➣ Sanofi
    ➣ AstraZeneca plc
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Peptide Therapeutics Market Characteristics

3. Peptide Therapeutics Market Trends And Strategies

4. Impact Of COVID-19 On Peptide Therapeutics

5. Peptide Therapeutics Market Size And Growth
5.1. Global Peptide Therapeutics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Peptide Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Peptide Therapeutics Market Segmentation
6.1. Global Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Generic
Branded
6.2. Global Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal of Route Administration
6.3. Global Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Cancer
Cardiovascular Diseases
Central Nervous Systems
Metabolic Disorders
Infections
Hematological Disorders
Gastrointestinal Disorders
Dermatology
Respiratory Disorders
Acromegaly
Other Applications

7. Peptide Therapeutics Market Regional And Country Analysis
7.1. Global Peptide Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Peptide Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Peptide Therapeutics Market
8.1. Asia-Pacific Peptide Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Peptide Therapeutics Market
9.1. China Peptide Therapeutics Market Overview
9.2. China Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Peptide Therapeutics Market
10.1. India Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Peptide Therapeutics Market
11.1. Japan Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Peptide Therapeutics Market
12.1. Australia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Peptide Therapeutics Market
13.1. Indonesia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Peptide Therapeutics Market
14.1. South Korea Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Peptide Therapeutics Market
15.1. Western Europe Peptide Therapeutics Market Overview
15.2. Western Europe Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Peptide Therapeutics Market
16.1. UK Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Peptide Therapeutics Market
17.1. Germany Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Peptide Therapeutics Market
18.1. France Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.2. France Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Peptide Therapeutics Market
19.1. Eastern Europe Peptide Therapeutics Market Overview
19.2. Eastern Europe Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Peptide Therapeutics Market
20.1. Russia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Peptide Therapeutics Market
21.1. North America Peptide Therapeutics Market Overview
21.2. North America Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Peptide Therapeutics Market
22.1. USA Peptide Therapeutics Market Overview
22.2. USA Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Peptide Therapeutics Market
23.1. South America Peptide Therapeutics Market Overview
23.2. South America Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Peptide Therapeutics Market
24.1. Brazil Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Peptide Therapeutics Market
25.1. Middle East Peptide Therapeutics Market Overview
25.2. Middle East Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Peptide Therapeutics Market
26.1. Africa Peptide Therapeutics Market Overview
26.2. Africa Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Peptide Therapeutics Market Competitive Landscape And Company Profiles
27.1. Peptide Therapeutics Market Competitive Landscape
27.2. Peptide Therapeutics Market Company Profiles
27.2.1. Amgen, Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pfizer, Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bristol-Myers Squibb Company
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Sanofi
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. AstraZeneca plc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Peptide Therapeutics Market

29. Peptide Therapeutics Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

この商品のレポートナンバー

0000033315

TOP